Q3 2024 Holdings
Filed 2024-11-14 | 71 holdings | $3.2B | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Argenx SE(ARGX) | SPONSORED ADR | 04016X101 | $197.9M | 365,000 | 6.3% |
| Dynavax Technologies Corp(DVAX) | COM NEW | 268158201 | $139.5M | 12,526,486 | 4.4% |
| Guardant Health Inc(GH) | COM | 40131M109 | $137.7M | 6,000,560 | 4.4% |
| Apellis Pharmaceuticals Inc(APLS) | COM | 03753U106 | $126.9M | 4,400,654 | 4.0% |
| Immunovant Inc(IMVT) | COM | 45258J102 | $123.9M | 4,347,464 | 3.9% |
| Springworks Therapeutics Inc | COM | 85205L107 | $123.2M | 3,843,900 | 3.9% |
| Dyne Therapeutics Inc(DYN) | COM | 26818M108 | $117.9M | 3,282,000 | 3.7% |
| Intra-Cellular Therapies Inc(ITCIEUR) | COM | 46116X101 | $117.1M | 1,600,693 | 3.7% |
| Ocular Therapeutix Inc(OCUL) | COM | 67576A100 | $110.7M | 12,721,460 | 3.5% |
| Intellia Therapeutics Inc(NTLA) | COM | 45826J105 | $101.7M | 4,950,000 | 3.2% |
| Alkermes PLC(ALKS) | SHS | G01767105 | $98.0M | 3,500,000 | 3.1% |
| Verona Pharma PLC(VRNA) | SPONSORED ADS | 925050106 | $91.5M | 3,180,025 | 2.9% |
| Ionis Pharmaceuticals Inc(IONS) | COM | 462222100 | $88.1M | 2,200,000 | 2.8% |
| Nurix Therapeutics Inc(NRIX) | COM | 67080M103 | $86.9M | 3,868,104 | 2.8% |
| Viridian Therapeutics Inc(VRDN) | COM | 92790C104 | $85.3M | 3,750,945 | 2.7% |
| Bicycle Therapeutics PLC(BCYC) | SPONSORED ADS | 088786108 | $80.3M | 3,548,001 | 2.5% |
| MBX Biosciences Inc(MBX) | COM | 55287L101 | $78.4M | 3,018,935 | 2.5% |
| Axsome Therapeutics Inc(AXSM) | COM | 05464T104 | $77.0M | 857,219 | 2.4% |
| Pliant Therapeutics Inc(PLRX) | COM | 729139105 | $66.9M | 5,972,257 | 2.1% |
| Apogee Therapeutics Inc(APGE) | COM | 03770N101 | $58.7M | 1,000,000 | 1.9% |
| Autolus Therapeutics PLC(AUTL) | SPON ADS | 05280R100 | $55.4M | 15,272,172 | 1.8% |
| Structure Therapeutics Inc(GPCR) | SPONSORED ADS | 86366E106 | $53.6M | 1,220,508 | 1.7% |
| Olema Pharmaceuticals Inc(OLMA) | COM | 68062P106 | $47.8M | 4,000,000 | 1.5% |
| Terns Pharmaceuticals Inc(TERN) | COM | 880881107 | $46.5M | 5,576,558 | 1.5% |
| 4D Molecular Therapeutics in(FDMT) | COM | 35104E100 | $44.3M | 4,096,452 | 1.4% |
| Abivax SA(ABVX) | SPONSORED ADS | 00370M103 | $41.2M | 3,579,209 | 1.3% |
| TG Therapeutics Inc(TGTX) | COM | 88322Q108 | $40.3M | 1,725,000 | 1.3% |
| Mind Medicine Mindmed Inc(BRD1EUR) | COM NEW | 60255C885 | $40.2M | 7,065,099 | 1.3% |
| Kura Oncology Inc(KURA) | COM | 50127T109 | $38.4M | 1,963,505 | 1.2% |
| Geron Corp(GERN) | COM | 374163103 | $34.4M | 7,575,049 | 1.1% |
| Cytokinetics Inc(CYTK) | COM NEW | 23282W605 | $33.3M | 629,906 | 1.1% |
| Oruka Therapeutics Inc(ORKA) | COM | 687604108 | $30.3M | 1,235,187 | 1.0% |
| ANI Pharmaceuticals Inc(ANIP) | COM | 00182C103 | $30.1M | 504,828 | 1.0% |
| Spyre Therapeutics Inc(SYRE) | COM NEW | 00773J202 | $29.4M | 1,000,000 | 0.9% |
| Edgewise Therapeutics Inc(EWTX) | COM | 28036F105 | $29.4M | 1,100,536 | 0.9% |
| Kymera Therapeutics Inc(KYMR) | COM | 501575104 | $28.4M | 600,326 | 0.9% |
| Korro BIO Inc(KRRO) | COM | 500946108 | $28.4M | 850,000 | 0.9% |
| Avidity Biosciences Inc(RNA) | COM | 05370A108 | $21.8M | 475,000 | 0.7% |
| Centessa Pharmaceuticals PLC(CNTA) | SPONSORED ADS | 152309100 | $21.6M | 1,350,000 | 0.7% |
| Alector Inc(ALEC) | COM | 014442107 | $21.6M | 4,631,998 | 0.7% |
| Nektar Therapeutics(NKTREUR) | COM | 640268108 | $20.7M | 15,922,655 | 0.7% |
| 89Bio Inc(ETNBGBP) | COM | 282559103 | $20.5M | 2,766,512 | 0.6% |
| Bicara Therapeutics Inc(BCAX) | COM | 055477103 | $20.3M | 796,852 | 0.6% |
| Akero Therapeutics Inc(AKRO) | COM | 00973Y108 | $19.8M | 689,784 | 0.6% |
| Fate Therapeutics Inc(FATE) | COM | 31189P102 | $19.5M | 5,572,607 | 0.6% |
| Silence Therapeutics PLC(SLN) | ADS | 82686Q101 | $18.2M | 1,000,000 | 0.6% |
| Axsome Therapeutics Inc(AXSM)Call | COM | 05464T104 | $18.0M | 200,000 | 0.6% |
| Engene Holdings Inc(ENGN) | COM | 29286M105 | $17.2M | 2,607,633 | 0.5% |
| Editas Medicine Inc(EDIT) | COM | 28106W103 | $16.7M | 4,900,334 | 0.5% |
| Xencor Inc(XNCR) | COM | 98401F105 | $16.1M | 800,000 | 0.5% |